Computer Guided Placement of Zygomatic Implants in Two Different Approaches
Launched by CAIRO UNIVERSITY · Nov 8, 2023
Trial Information
Current as of July 01, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at two different methods for placing zygomatic implants, which are special dental implants used when patients have significant bone loss in the upper jaw (also known as the maxilla). The study aims to see which method, either placing the implants through the sinus or around it, results in fewer complications after surgery. This information could help doctors choose the best approach for patients who need these implants to restore their ability to chew and smile.
To participate in this trial, patients must have a severely damaged upper jaw that can't be fixed with other treatments and enough bone height in the front part of the jaw to support conventional implants. Additionally, candidates should be in good overall health and motivated to undergo the procedure. Participants can expect to receive care from a team of professionals and might contribute to finding the best surgical approach for future patients needing similar treatments. Remember, this trial is currently recruiting participants of all genders, so if you or someone you know fits these criteria, it could be a great opportunity to help improve dental care for others.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Patients with severely atrophic edentulous upper arch (Cawood class IV, V, VI) that could not be restored by other type of treatment
- • 2. Patients who had at least 8-12 mm vertical bone height in anterior maxilla to allow installation of 2 conventional implants.
- • 3. Lacking posterior maxillary bone support due to significant sinus pneumatistion
- • 4. Good systemic health (ASA score I-II)
- • 5. Highly motivated patients.
- Exclusion Criteria:
- • 1. Patient not willing to give his/her informed consent.
- • 2. Patients with systemic disease that did not permit the surgical procedure (including general anaesthesia).
- • 3. Patients with uncontrolled diabetes or under bisphosphonate therapy.
- • 4. Heavy smoker.(\> 20 cigarettes daily)
- • 5. Patient with psychiatric problems, severe bruxism or other parafunctional habits.
- • 6. Acute sinusitis.
- • 7. Malignancy or pathology in Maxilla or Zygoma.
About Cairo University
Cairo University, a premier institution in Egypt, is dedicated to advancing medical research and education through innovative clinical trials. With a strong emphasis on improving healthcare outcomes, the university collaborates with various stakeholders to conduct rigorous scientific studies that address critical health challenges. Leveraging its extensive resources and expert faculty, Cairo University aims to contribute valuable insights to the medical community and enhance patient care both locally and globally. Through its commitment to ethical research practices and excellence, the university plays a pivotal role in shaping the future of healthcare in the region.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Cairo, , Egypt
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported